Summary
34 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 13 USD is left as free cash.
- It beat profit estimates 7 times in the last 8 quarters.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 4.8 years of operating profit.
- The share price is above the Bulios Fair Price.
- Revenue fell by 4.2% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 3.7% a year over 5 years. Over the last 3 years it fell by 4.2% a year. For the next fiscal year analysts expect revenue to grow by 3.4%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $410.7M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 2.63%
You receive $0.48 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 5
- Hold 7
- Sell 1
Today's price within the analysts' price targets
The average target of $22.17 is 20% above today's price. 38% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Brands 64%
- Generics 36%
By region
- Developed Markets Segment 60%
- Greater China Segment 16%
- Emerging Markets Segment 16%
- Japan, Australia and New Zealand Segment 8.4%
Brands brings in 64% of revenue.
Segments in detail